Bruce Poppe

29.5k total citations · 1 hit paper
83 papers, 19.1k citations indexed

About

Bruce Poppe is a scholar working on Molecular Biology, Genetics and Hematology. According to data from OpenAlex, Bruce Poppe has authored 83 papers receiving a total of 19.1k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Molecular Biology, 28 papers in Genetics and 19 papers in Hematology. Recurrent topics in Bruce Poppe's work include BRCA gene mutations in cancer (19 papers), Acute Myeloid Leukemia Research (13 papers) and Chronic Myeloid Leukemia Treatments (13 papers). Bruce Poppe is often cited by papers focused on BRCA gene mutations in cancer (19 papers), Acute Myeloid Leukemia Research (13 papers) and Chronic Myeloid Leukemia Treatments (13 papers). Bruce Poppe collaborates with scholars based in Belgium, France and Netherlands. Bruce Poppe's co-authors include Anne De Paepe, Nadine Van Roy, Jo Vandesompele, Frank Speleman, Katleen De Preter, Filip Pattyn, Kathleen Claes, Frank Speleman, Ilse Coene and Ludwine Messiaen and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Bruce Poppe

80 papers receiving 18.8k citations

Hit Papers

Accurate normalization of real-time quantitative RT-PCR d... 2002 2026 2010 2018 2002 5.0k 10.0k 15.0k

Peers

Bruce Poppe
Filip Pattyn Belgium
Alicia Oshlack Australia
Yang Liao Australia
Tania Nolan United Kingdom
Bruce Poppe
Citations per year, relative to Bruce Poppe Bruce Poppe (= 1×) peers Frank Speleman

Countries citing papers authored by Bruce Poppe

Since Specialization
Citations

This map shows the geographic impact of Bruce Poppe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce Poppe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce Poppe more than expected).

Fields of papers citing papers by Bruce Poppe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruce Poppe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce Poppe. The network helps show where Bruce Poppe may publish in the future.

Co-authorship network of co-authors of Bruce Poppe

This figure shows the co-authorship network connecting the top 25 collaborators of Bruce Poppe. A scholar is included among the top collaborators of Bruce Poppe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruce Poppe. Bruce Poppe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Devos, Timothy, et al.. (2023). Germline heterozygous SH2B3‐mutations and (idiopathic) erythrocytosis: Detection of a previously undescribed mutation. SHILAP Revista de lepidopterología. 4(4). 1143–1147. 1 indexed citations
2.
Heetvelde, Mattias Van, Mieke Van Bockstal, Bruce Poppe, et al.. (2018). Accurate detection and quantification of epigenetic and genetic second hits in BRCA1 and BRCA2 -associated hereditary breast and ovarian cancer reveals multiple co-acting second hits. Cancer Letters. 425. 125–133. 12 indexed citations
3.
Peirs, Sofie, Viktoras Frismantas, Filip Matthijssens, et al.. (2016). Targeting BET family proteins improves the therapeutic efficacy of BCL-2 inhibition in T-cell acute lymphoblastic leukemia. Haematologica. 101. 201–202. 1 indexed citations
4.
Robays, Jo, Sabine Stordeur, Tom Van Maerken, et al.. (2015). Oncogenetic testing and follow-up for women with familial breast/ovarian cancer, Li-Fraumeni syndrome and Cowden syndrome. 1 indexed citations
5.
Ghazavi, Farzaneh, Tim Lammens, Nadine Van Roy, et al.. (2015). Molecular basis and clinical significance of genetic aberrations in B-cell precursor acute lymphoblastic leukemia. Experimental Hematology. 43(8). 640–653. 17 indexed citations
6.
Chiaie, Barbara Delle, Roos Leroy, Bert Callewaert, et al.. (2012). Adults with Down syndrome: health/care considerations for health professionals. Ghent University Academic Bibliography (Ghent University).
7.
Messiaen, Peter, Ward De Spiegelaere, José Alcamı́, et al.. (2012). Characterization of LEDGF/p75 Genetic Variants and Association with HIV-1 Disease Progression. PLoS ONE. 7(11). e50204–e50204. 10 indexed citations
8.
Terryn, Wim, Pierre Cochat, Roseline Froissart, et al.. (2012). Fabry nephropathy: indications for screening and guidance for diagnosis and treatment by the European Renal Best Practice. Nephrology Dialysis Transplantation. 28(3). 505–517. 69 indexed citations
9.
Vlierberghe, Pieter Van, An De Weer, Pieter Mestdagh, et al.. (2009). Comparison of miRNA profiles of microdissected Hodgkin/Reed‐Sternberg cells and Hodgkin cell lines versus CD77+ B‐cells reveals a distinct subset of differentially expressed miRNAs. British Journal of Haematology. 147(5). 686–690. 38 indexed citations
10.
Weer, An De, Bruce Poppe, Barbara Cauwelier, et al.. (2008). EVI1activation in blast crisis CML due to juxtaposition to the rare 17q22 partner region as part of a 4-way variant translocation t(9;22). BMC Cancer. 8(1). 193–193. 8 indexed citations
11.
Feys, Tom, Bruce Poppe, Katleen De Preter, et al.. (2007). A detailed inventory of DNA copy number alterations in four commonly used Hodgkin lymphoma cell lines. Ghent University Academic Bibliography (Ghent University). 1 indexed citations
12.
Feys, Tom, Bruce Poppe, Katleen De Preter, et al.. (2007). A detailed inventory of DNA copy number alterations in four commonly used Hodgkin's lymphoma cell lines. Haematologica. 92(7). 913–920. 26 indexed citations
13.
Poppe, Bruce, Nurten Yigit, Barbara De Moerloose, et al.. (2005). HOXA gene cluster rearrangement in a t(7;9)(p15;q34) in a child with MDS. Cancer Genetics and Cytogenetics. 162(1). 82–84. 3 indexed citations
14.
Claes, Kathleen, Bruce Poppe, Ilse Coene, Anne De Paepe, & Ludwine Messiaen. (2004). BRCA1 and BRCA2 germline mutation spectrum and frequencies in Belgian breast/ovarian cancer families. British Journal of Cancer. 90(6). 1244–1251. 38 indexed citations
15.
Claes, Kathleen, Bruce Poppe, Ilse Coene, Anne De Paepe, & Ludwine Messiaen. (2003). BRCA1/2 mutation spectrum and frequencies in Belgian breast/ovarian cancer families. The American Journal of Human Genetics. 73(5). 232–232.
16.
Poppe, Bruce, et al.. (2003). High resolution molecular cytogenetics and MDS1, MDS1/EVI1 and EVI1 expression patterns in rearrangements involving 3q26. The Hematology Journal. 4. 1 indexed citations
17.
Claes, Kathleen, Bruce Poppe, Eva Macháčková, et al.. (2003). Differentiating pathogenic mutations from polymorphic alterations in the splice sites of BRCA1 and BRCA2. Genes Chromosomes and Cancer. 37(3). 314–320. 63 indexed citations
18.
Limbergen, Heidi Van, Bruce Poppe, Ann Janssens, et al.. (2002). Molecular cytogenetic analysis of 10;11 rearrangements in acute myeloid leukemia. Leukemia. 16(3). 344–351. 40 indexed citations
19.
Poppe, Bruce, Nurten Yigit, Peter Marynen, et al.. (2001). Molecular characterization of a t(2;3)(p23;q26): A recurrent translocation involving the EVI1 gene. Ghent University Academic Bibliography (Ghent University). 2 indexed citations
20.
Claes, Kathleen, Bruce Poppe, Michel De Vos, et al.. (2000). Identification and characterisation of a founder mutation in the Belgian breast/ovarian cancer population. The American Journal of Human Genetics. 67. 80–80. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026